Osmotic Laxative [EPC]

Osmotic Laxative [EPC] was reported 295633 times

Drugs of the Osmotic Laxative [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INAPPROPRIATE PRESCRIBING 467 0.7581
1 APPENDICOLITH 280 0.7235
2 VAGINAL FLATULENCE 199 0.6568
3 INFUSION SITE DISCHARGE 413 0.2353
4 SEDATION COMPLICATION 588 0.2302
5 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1016 0.1865
6 GRANULOCYTE COUNT DECREASED 340 0.1832
7 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 190 0.1789
8 INFUSION SITE HAEMORRHAGE 526 0.1597
9 MYELOSUPPRESSION 5715 0.1585
10 DEVICE INFUSION ISSUE 391 0.1575
11 CREATININE RENAL CLEARANCE DECREASED 621 0.1550
12 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1052 0.1467
13 AMMONIA INCREASED 740 0.1449
14 HYPERPARATHYROIDISM SECONDARY 348 0.1388
15 FEMALE GENITAL TRACT FISTULA 235 0.1375
16 NEPHROGENIC ANAEMIA 637 0.1374
17 INFUSION SITE INFECTION 312 0.1341
18 HYPERPHOSPHATAEMIA 287 0.1334
19 INFUSION SITE SWELLING 813 0.1291
20 INFUSION SITE PAIN 1615 0.1252
21 INFUSION SITE ERYTHEMA 1022 0.1211
22 CYSTIC FIBROSIS 655 0.1182
23 INCORRECT PRODUCT ADMINISTRATION DURATION 2517 0.1161
24 RADICULOPATHY 302 0.1145
25 INFUSION SITE BRUISING 245 0.1133
26 ESSENTIAL HYPERTENSION 204 0.1114
27 CHRONIC SINUSITIS 413 0.1099
28 INFUSION SITE PRURITUS 341 0.1080
29 VASCULAR DEVICE INFECTION 485 0.1068
30 INCORRECT DRUG ADMINISTRATION DURATION 2922 0.1038
31 BLOOD PHOSPHORUS INCREASED 283 0.1035
32 HEPATIC ENCEPHALOPATHY 953 0.1020
33 PRODUCT PRESCRIBING ISSUE 2190 0.1004
34 FAECES HARD 387 0.0994
35 HYPERVOLAEMIA 457 0.0924
36 PROCTITIS 257 0.0917
37 ABNORMAL FAECES 745 0.0908
38 INFUSION SITE REACTION 268 0.0896
39 HEREDITARY ANGIOEDEMA 930 0.0866
40 FAECALOMA 469 0.0855
41 AORTIC ARTERIOSCLEROSIS 217 0.0842
42 BLOOD CALCIUM DECREASED 947 0.0841
43 BLOOD CHLORIDE DECREASED 217 0.0841
44 REBOUND ACID HYPERSECRETION 251 0.0829
45 CATHETER SITE PAIN 213 0.0820
46 HYPERNATRAEMIA 403 0.0808
47 INFREQUENT BOWEL MOVEMENTS 198 0.0794
48 INCORRECT DRUG ADMINISTRATION RATE 337 0.0791
49 GASTROINTESTINAL MOTILITY DISORDER 420 0.0784
50 AORTIC STENOSIS 270 0.0775
51 FAILURE TO THRIVE 400 0.0770
52 ORTHOPNOEA 245 0.0769
53 CATHETER SITE HAEMORRHAGE 192 0.0767
54 RALES 445 0.0766
55 BREATH SOUNDS ABNORMAL 376 0.0762
56 ORTHOSTATIC HYPOTENSION 1322 0.0758
57 RHINITIS ALLERGIC 337 0.0756
58 RHINOVIRUS INFECTION 290 0.0744
59 ATELECTASIS 707 0.0731
60 METABOLIC ENCEPHALOPATHY 216 0.0719
61 JAUNDICE CHOLESTATIC 254 0.0718
62 HYPERPYREXIA 300 0.0708
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 352 0.0695
64 HYPOKALAEMIA 3205 0.0694
65 SEASONAL ALLERGY 977 0.0690
66 DRUG EFFECT DELAYED 308 0.0679
67 APLASTIC ANAEMIA 350 0.0669
68 MULTIPLE ALLERGIES 523 0.0666
69 PRODUCT SOLUBILITY ABNORMAL 336 0.0665
70 HAEMORRHAGIC ANAEMIA 290 0.0659
71 HYPOPHOSPHATAEMIA 487 0.0658
72 INSURANCE ISSUE 1007 0.0658
73 BOWEL MOVEMENT IRREGULARITY 499 0.0651
74 END STAGE RENAL DISEASE 1179 0.0646
75 ACUTE RESPIRATORY FAILURE 1240 0.0644
76 THERAPEUTIC AGENT TOXICITY 214 0.0641
77 PRODUCT USE ISSUE 12058 0.0641
78 HAEMOGLOBIN INCREASED 292 0.0640
79 MACULAR DEGENERATION 756 0.0632
80 FAECES SOFT 459 0.0630
81 HYPOVOLAEMIA 369 0.0630
82 IRON DEFICIENCY 279 0.0620
83 PRODUCT TASTE ABNORMAL 838 0.0618
84 FAECAL INCONTINENCE 296 0.0616
85 INFUSION SITE EXTRAVASATION 382 0.0613
86 TACHYPNOEA 832 0.0611
87 NEUTROPHIL COUNT DECREASED 2491 0.0611
88 BRONCHIECTASIS 411 0.0609
89 DERMATITIS CONTACT 676 0.0592
90 BLOOD POTASSIUM DECREASED 1752 0.0582
91 LYMPHOEDEMA 400 0.0578
92 TRICUSPID VALVE INCOMPETENCE 454 0.0571
93 EXPIRED PRODUCT ADMINISTERED 1890 0.0568
94 ANAL INCONTINENCE 510 0.0566
95 CARDIAC MURMUR 489 0.0565
96 DIVERTICULUM INTESTINAL 246 0.0562
97 SKIN ABRASION 265 0.0560
98 RIGHT VENTRICULAR FAILURE 392 0.0559
99 PULMONARY HYPERTENSION 1165 0.0559
100 PULMONARY FUNCTION TEST DECREASED 244 0.0557
101 RED CELL DISTRIBUTION WIDTH INCREASED 230 0.0553
102 BLOOD ALBUMIN DECREASED 439 0.0553
103 DECUBITUS ULCER 450 0.0552
104 LEFT VENTRICULAR HYPERTROPHY 235 0.0549
105 TROPONIN INCREASED 414 0.0544
106 MITRAL VALVE INCOMPETENCE 615 0.0543
107 HYPERLIPIDAEMIA 649 0.0543
108 HYPONATRAEMIA 3056 0.0542
109 INCORRECT DOSAGE ADMINISTERED 265 0.0541
110 POOR VENOUS ACCESS 560 0.0541
111 FEBRILE NEUTROPENIA 3580 0.0539
112 HYPERKALAEMIA 1890 0.0538
113 ELECTROLYTE IMBALANCE 625 0.0537
114 PROTHROMBIN TIME PROLONGED 321 0.0536
115 VENTRICULAR FIBRILLATION 595 0.0535
116 ASCITES 1571 0.0534
117 PRODUCT LABEL CONFUSION 311 0.0533
118 HOSPICE CARE 527 0.0533
119 BLOOD URIC ACID INCREASED 308 0.0533
120 POOR QUALITY DRUG ADMINISTERED 344 0.0531
121 FREQUENT BOWEL MOVEMENTS 1431 0.0529
122 ABDOMINAL TENDERNESS 263 0.0529
123 CYTOKINE RELEASE SYNDROME 1058 0.0527
124 BENIGN PROSTATIC HYPERPLASIA 269 0.0520
125 CARDIOGENIC SHOCK 745 0.0519
126 BLOOD MAGNESIUM DECREASED 448 0.0519
127 TEMPERATURE INTOLERANCE 535 0.0518
128 HYPOMANIA 190 0.0516
129 MALNUTRITION 575 0.0513
130 SMALL INTESTINAL OBSTRUCTION 632 0.0513
131 ARTERIOSCLEROSIS CORONARY ARTERY 339 0.0511
132 COLITIS MICROSCOPIC 242 0.0510
133 CARDIOMEGALY 628 0.0510
134 HYPOXIA 1796 0.0509
135 CLOSTRIDIUM DIFFICILE COLITIS 536 0.0505
136 CONSTIPATION 11015 0.0505
137 GASTROINTESTINAL SOUNDS ABNORMAL 249 0.0502
138 PROTEIN TOTAL DECREASED 189 0.0501
139 BLOOD SODIUM DECREASED 942 0.0499
140 ORAL CANDIDIASIS 647 0.0491
141 LOWER GASTROINTESTINAL HAEMORRHAGE 363 0.0491
142 FLATULENCE 2782 0.0490
143 RENAL FAILURE CHRONIC 375 0.0487
144 UPPER GASTROINTESTINAL HAEMORRHAGE 819 0.0486
145 HYPOMAGNESAEMIA 677 0.0486
146 BACTERAEMIA 572 0.0481
147 LEFT VENTRICULAR DYSFUNCTION 321 0.0479
148 PRODUCT ODOUR ABNORMAL 501 0.0478
149 ATRIAL FLUTTER 381 0.0477
150 NEUTROPENIC SEPSIS 341 0.0477
151 IRON DEFICIENCY ANAEMIA 440 0.0476
152 PNEUMONIA ASPIRATION 1183 0.0473
153 ATRIOVENTRICULAR BLOCK FIRST DEGREE 204 0.0470
154 APPENDICITIS 439 0.0470
155 MYASTHENIA GRAVIS 379 0.0469
156 PSEUDOMONAS INFECTION 402 0.0468
157 WHITE BLOOD CELL COUNT DECREASED 5043 0.0465
158 HAEMATOCRIT DECREASED 913 0.0460
159 ABDOMINAL DISTENSION 4802 0.0460
160 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1550 0.0458
161 DYSPNOEA EXERTIONAL 1724 0.0457
162 BLOOD UREA INCREASED 765 0.0456
163 MENTAL STATUS CHANGES 1268 0.0456
164 FLUID OVERLOAD 664 0.0456
165 HYPOALBUMINAEMIA 354 0.0455
166 ESCHERICHIA URINARY TRACT INFECTION 191 0.0449
167 THERAPEUTIC PRODUCT EFFECT DELAYED 204 0.0447
168 BLOOD BILIRUBIN INCREASED 1205 0.0446
169 BUNDLE BRANCH BLOCK LEFT 188 0.0443
170 HAEMORRHOIDAL HAEMORRHAGE 216 0.0442
171 SPUTUM DISCOLOURED 418 0.0440
172 ILEUS 547 0.0440
173 DIVERTICULUM 312 0.0439
174 RENAL TUBULAR NECROSIS 429 0.0437
175 RENAL FUNCTION TEST ABNORMAL 203 0.0437
176 ECONOMIC PROBLEM 662 0.0436
177 STAPHYLOCOCCAL SEPSIS 215 0.0435
178 FAECES DISCOLOURED 943 0.0435
179 HIATUS HERNIA 562 0.0434
180 GRANULOCYTOPENIA 247 0.0433
181 TRANSFUSION 454 0.0433
182 URINE OUTPUT DECREASED 377 0.0431
183 PULSE ABSENT 205 0.0431
184 OXYGEN SATURATION DECREASED 2418 0.0430
185 PRODUCTIVE COUGH 2018 0.0422
186 SPINAL OSTEOARTHRITIS 370 0.0421
187 DRUG PRESCRIBING ERROR 808 0.0420
188 PROCTALGIA 270 0.0420
189 UROSEPSIS 387 0.0419
190 SLEEP APNOEA SYNDROME 800 0.0419
191 ASPIRATION 458 0.0418
192 BLOOD POTASSIUM INCREASED 675 0.0415
193 EXPIRED DRUG ADMINISTERED 205 0.0414
194 UPPER RESPIRATORY TRACT INFECTION 1910 0.0413
195 HEPATIC CIRRHOSIS 772 0.0410
196 PLEURAL EFFUSION 2488 0.0408
197 ELECTROCARDIOGRAM ABNORMAL 320 0.0407
198 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2127 0.0407
199 HAEMORRHOIDS 791 0.0405
200 PULMONARY ARTERIAL HYPERTENSION 587 0.0405
201 AGRANULOCYTOSIS 751 0.0404
202 LUNG INFILTRATION 356 0.0403
203 RESPIRATORY SYNCYTIAL VIRUS INFECTION 350 0.0402
204 GENERALISED OEDEMA 496 0.0400
205 NEUTROPHIL COUNT INCREASED 410 0.0400
206 CHRONIC KIDNEY DISEASE 3042 0.0400
207 HYDRONEPHROSIS 298 0.0398
208 FLUID RETENTION 2016 0.0396
209 MULTIPLE INJURIES 249 0.0395
210 LYMPHOCYTE COUNT DECREASED 698 0.0394
211 DEHYDRATION 5254 0.0393
212 RESPIRATORY TRACT INFECTION 1025 0.0393
213 INABILITY TO AFFORD MEDICATION 390 0.0392
214 SEPSIS 4377 0.0392
215 PERIPHERAL VASCULAR DISORDER 202 0.0392
216 ACUTE KIDNEY INJURY 5991 0.0391
217 ESCHERICHIA INFECTION 321 0.0390
218 WEIGHT FLUCTUATION 408 0.0390
219 ENCEPHALOPATHY 957 0.0389
220 TOXIC EPIDERMAL NECROLYSIS 591 0.0389
221 INTERNATIONAL NORMALISED RATIO INCREASED 1109 0.0389
222 OESOPHAGITIS 424 0.0388
223 FULL BLOOD COUNT DECREASED 777 0.0385
224 COAGULOPATHY 641 0.0384
225 APPETITE DISORDER 255 0.0384
226 VENTRICULAR TACHYCARDIA 635 0.0384
227 SINUS TACHYCARDIA 545 0.0383
228 HYPERAMMONAEMIA 191 0.0382
229 OEDEMA PERIPHERAL 4650 0.0381
230 HEPATIC FUNCTION ABNORMAL 1415 0.0379
231 RESPIRATORY RATE INCREASED 336 0.0378
232 LEUKOCYTOSIS 683 0.0377
233 PRODUCT DISTRIBUTION ISSUE 350 0.0377
234 BACTERIAL INFECTION 702 0.0376
235 RENAL FAILURE ACUTE 1595 0.0375
236 COMPRESSION FRACTURE 201 0.0375
237 HAEMOPTYSIS 1046 0.0375
238 ECCHYMOSIS 256 0.0373
239 DEVICE RELATED INFECTION 574 0.0373
240 TIC 203 0.0372
241 GOUT 667 0.0371
242 BLOOD CALCIUM INCREASED 326 0.0371
243 VENTRICULAR EXTRASYSTOLES 386 0.0371
244 UNRESPONSIVE TO STIMULI 956 0.0370
245 HYPERCALCAEMIA 456 0.0369
246 CARDIAC FAILURE CONGESTIVE 2958 0.0368
247 SEDATION 964 0.0368
248 PLATELET COUNT DECREASED 3919 0.0367
249 SUPRAVENTRICULAR TACHYCARDIA 352 0.0367
250 ATRIAL FIBRILLATION 3578 0.0367
251 HYPOTENSION 7368 0.0367
252 BLOOD ALKALINE PHOSPHATASE INCREASED 912 0.0367
253 EXERCISE TOLERANCE DECREASED 211 0.0366
254 RESPIRATORY DISTRESS 1007 0.0364
255 CELLULITIS 1829 0.0363
256 RECTAL HAEMORRHAGE 1555 0.0362
257 FLANK PAIN 339 0.0361
258 SKIN LACERATION 393 0.0361
259 HYPOCALCAEMIA 680 0.0359
260 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 218 0.0358
261 RED BLOOD CELL COUNT DECREASED 1022 0.0357
262 CARDIAC FAILURE ACUTE 237 0.0355
263 TENDERNESS 370 0.0355
264 CARDIOMYOPATHY 524 0.0354
265 RENAL CYST 280 0.0352
266 RESPIRATORY FAILURE 2570 0.0352
267 URINARY TRACT INFECTION 6006 0.0352
268 HYPOPHAGIA 899 0.0351
269 COVID-19 PNEUMONIA 412 0.0349
270 PNEUMONIA BACTERIAL 320 0.0348
271 IMPAIRED GASTRIC EMPTYING 475 0.0348
272 GASTROENTERITIS VIRAL 627 0.0347
273 SCOLIOSIS 215 0.0347
274 SEPTIC SHOCK 1510 0.0347
275 ON AND OFF PHENOMENON 191 0.0344
276 PERICARDIAL EFFUSION 792 0.0342
277 INFUSION RELATED REACTION 2267 0.0342
278 POSTOPERATIVE WOUND INFECTION 231 0.0342
279 HAEMOGLOBIN DECREASED 3504 0.0341
280 PAIN IN JAW 962 0.0339
281 ANAEMIA 6470 0.0339
282 GASTROOESOPHAGEAL REFLUX DISEASE 2722 0.0338
283 RESPIRATION ABNORMAL 233 0.0338
284 PNEUMONIA 10932 0.0337
285 PARAESTHESIA ORAL 487 0.0337
286 BRONCHITIS 2494 0.0337
287 GASTROINTESTINAL HAEMORRHAGE 2811 0.0336
288 OEDEMA 1823 0.0336
289 DEVICE OCCLUSION 473 0.0336
290 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 199 0.0336
291 CHOLELITHIASIS 1101 0.0335
292 EMPHYSEMA 338 0.0335
293 COLITIS ISCHAEMIC 226 0.0335
294 PULMONARY OEDEMA 1492 0.0333
295 PRODUCT ADMINISTRATION INTERRUPTED 261 0.0332
296 DIZZINESS POSTURAL 322 0.0332
297 MICTURITION URGENCY 379 0.0331
298 INTERVERTEBRAL DISC DEGENERATION 306 0.0330
299 BLOOD TEST ABNORMAL 464 0.0330
300 PULMONARY CONGESTION 435 0.0330
301 ARTERIOSCLEROSIS 310 0.0329
302 NOCTURIA 399 0.0328
303 DEPRESSED LEVEL OF CONSCIOUSNESS 1297 0.0328
304 RETCHING 694 0.0325
305 DIVERTICULITIS 902 0.0325
306 PANCYTOPENIA 1808 0.0323
307 CYSTITIS 1030 0.0323
308 HEPATIC FAILURE 975 0.0323
309 PULMONARY MASS 481 0.0323
310 NEURALGIA 785 0.0323
311 SINUSITIS 3305 0.0322
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 913 0.0322
313 EAR INFECTION 857 0.0322
314 SHOCK HAEMORRHAGIC 262 0.0322
315 CANDIDA INFECTION 543 0.0321
316 URINARY RETENTION 1070 0.0320
317 TUMOUR LYSIS SYNDROME 282 0.0320
318 PRODUCT PREPARATION ISSUE 210 0.0320
319 ABDOMINAL PAIN 7436 0.0319
320 SINUS CONGESTION 429 0.0317
321 UPPER-AIRWAY COUGH SYNDROME 261 0.0316
322 FULL BLOOD COUNT ABNORMAL 335 0.0316
323 UNDERDOSE 2309 0.0316
324 RENAL FAILURE 4195 0.0316
325 OLIGURIA 196 0.0315
326 HAEMATEMESIS 800 0.0315
327 GROIN PAIN 276 0.0314
328 VITAMIN D DEFICIENCY 306 0.0313
329 BLOOD CREATININE INCREASED 2034 0.0311
330 SINUS BRADYCARDIA 301 0.0311
331 COGNITIVE DISORDER 1454 0.0311
332 GASTROINTESTINAL INFECTION 279 0.0311
333 INCONTINENCE 328 0.0310
334 RESPIRATORY TRACT CONGESTION 492 0.0309
335 MELAENA 679 0.0308
336 STAPHYLOCOCCAL INFECTION 1014 0.0307
337 ASPARTATE AMINOTRANSFERASE INCREASED 1627 0.0306
338 GASTRITIS 804 0.0305
339 PETECHIAE 318 0.0304
340 MOUTH HAEMORRHAGE 223 0.0304
341 CHEST DISCOMFORT 3113 0.0304
342 MUSCULOSKELETAL CHEST PAIN 469 0.0303
343 SPINAL COMPRESSION FRACTURE 250 0.0302
344 COLITIS 1145 0.0302
345 EPISTAXIS 2256 0.0301
346 PRODUCT USE COMPLAINT 475 0.0301
347 DELIRIUM 1046 0.0301
348 DEFAECATION URGENCY 211 0.0301
349 PNEUMOTHORAX 476 0.0300
350 CYANOSIS 472 0.0300
351 ACIDOSIS 229 0.0299
352 CYTOPENIA 366 0.0299
353 FALL 9902 0.0297
354 LUNG INFECTION 461 0.0296
355 BODY TEMPERATURE INCREASED 604 0.0296
356 SINUS DISORDER 585 0.0295
357 SKIN INFECTION 331 0.0295
358 URINARY INCONTINENCE 874 0.0295
359 INTESTINAL OBSTRUCTION 1109 0.0294
360 DIARRHOEA 18950 0.0293
361 LIGAMENT SPRAIN 290 0.0293
362 WHITE BLOOD CELL COUNT INCREASED 1125 0.0293
363 BALANCE DISORDER 2534 0.0293
364 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 301 0.0293
365 VIRAL INFECTION 975 0.0293
366 CHILLS 3427 0.0292
367 BLOOD IRON DECREASED 346 0.0291
368 PRESYNCOPE 707 0.0290
369 ADRENAL INSUFFICIENCY 352 0.0290
370 HEAD INJURY 916 0.0289
371 EJECTION FRACTION DECREASED 449 0.0289
372 BRADYCARDIA 1532 0.0289
373 BLOOD PRESSURE DECREASED 1918 0.0288
374 MOUTH ULCERATION 608 0.0288
375 SPLENOMEGALY 338 0.0288
376 MUCOSAL INFLAMMATION 755 0.0288
377 BONE MARROW FAILURE 586 0.0288
378 TRANSAMINASES INCREASED 640 0.0288
379 NEPHROPATHY 268 0.0287
380 BLADDER DISORDER 285 0.0287
381 POLYURIA 235 0.0287
382 TORSADE DE POINTES 225 0.0287
383 CONFUSIONAL STATE 4630 0.0286
384 HICCUPS 235 0.0286
385 SUBDURAL HAEMATOMA 409 0.0285
386 HYPERBILIRUBINAEMIA 294 0.0284
387 CHOLECYSTITIS 338 0.0283
388 PYREXIA 9804 0.0283
389 DYSURIA 1042 0.0283
390 SCHIZOPHRENIA 344 0.0283
391 WHEEZING 1675 0.0282
392 ULCER 449 0.0282
393 ALANINE AMINOTRANSFERASE INCREASED 1726 0.0281
394 HALLUCINATION 2112 0.0280
395 RIB FRACTURE 576 0.0280
396 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 480 0.0280
397 BRAIN OEDEMA 351 0.0278
398 VOMITING 13025 0.0277
399 THROMBOCYTOPENIA 3093 0.0276
400 DECREASED APPETITE 6417 0.0276
401 C-REACTIVE PROTEIN INCREASED 1005 0.0276
402 BODY HEIGHT DECREASED 295 0.0276
403 HAEMATURIA 942 0.0275
404 HAEMATOMA 711 0.0274
405 OSTEOPENIA 415 0.0273
406 LARGE INTESTINE POLYP 189 0.0273
407 HEPATOMEGALY 268 0.0272
408 ORAL PAIN 610 0.0272
409 TASTE DISORDER 552 0.0272
410 EYE INFECTION 307 0.0272
411 MULTI-ORGAN FAILURE 469 0.0271
412 CLOSTRIDIUM DIFFICILE INFECTION 592 0.0271
413 CORONARY ARTERY DISEASE 820 0.0271
414 PHARYNGITIS STREPTOCOCCAL 293 0.0270
415 MYOCARDIAL ISCHAEMIA 308 0.0270
416 DYSPNOEA 15289 0.0270
417 GASTROINTESTINAL PAIN 297 0.0270
418 PELVIC FRACTURE 210 0.0269
419 GASTROENTERITIS 393 0.0269
420 ASTHENIA 10125 0.0269
421 RHINITIS 217 0.0269
422 TACHYCARDIA 2386 0.0268
423 WEIGHT DECREASED 7491 0.0268
424 FIBROMYALGIA 652 0.0268
425 GAMMA-GLUTAMYLTRANSFERASE INCREASED 594 0.0268
426 HYPERGLYCAEMIA 976 0.0268
427 POOR QUALITY PRODUCT ADMINISTERED 281 0.0266
428 TOOTH INFECTION 351 0.0266
429 TOOTH ABSCESS 271 0.0266
430 DEEP VEIN THROMBOSIS 1720 0.0264
431 BLOOD PRESSURE ABNORMAL 526 0.0264
432 TUBULOINTERSTITIAL NEPHRITIS 495 0.0264
433 BLOOD PRESSURE DIASTOLIC DECREASED 194 0.0263
434 SECRETION DISCHARGE 329 0.0262
435 CIRCULATORY COLLAPSE 447 0.0262
436 SUBARACHNOID HAEMORRHAGE 267 0.0262
437 VAGINAL DISCHARGE 265 0.0262
438 PALLOR 712 0.0261
439 CARDIAC ARREST 2157 0.0261
440 GLOMERULAR FILTRATION RATE DECREASED 321 0.0261
441 LETHARGY 1502 0.0261
442 RENAL INJURY 774 0.0260
443 COUGH 7263 0.0259
444 HEPATIC CYTOLYSIS 330 0.0259
445 LIMB INJURY 703 0.0259
446 WOUND INFECTION 283 0.0258
447 GINGIVAL BLEEDING 352 0.0258
448 DEMENTIA 720 0.0257
449 PNEUMONITIS 699 0.0256
450 INTERNAL HAEMORRHAGE 293 0.0256
451 HYPERCHOLESTEROLAEMIA 247 0.0256
452 LIVER INJURY 627 0.0255
453 INCREASED TENDENCY TO BRUISE 235 0.0255
454 HYPOTHYROIDISM 815 0.0255
455 CHEST PAIN 4722 0.0255
456 GENERAL PHYSICAL HEALTH DETERIORATION 2949 0.0255
457 DRUG-INDUCED LIVER INJURY 799 0.0254
458 NEUROPATHY PERIPHERAL 2421 0.0254
459 CARPAL TUNNEL SYNDROME 356 0.0254
460 HAEMATOCHEZIA 1402 0.0254
461 KIDNEY INFECTION 498 0.0254
462 JOINT DISLOCATION 268 0.0253
463 PULMONARY HAEMORRHAGE 198 0.0253
464 TRANSIENT ISCHAEMIC ATTACK 854 0.0253
465 PRODUCT USE IN UNAPPROVED INDICATION 6272 0.0253
466 NASAL CONGESTION 1487 0.0253
467 LOCALISED INFECTION 610 0.0252
468 SYNCOPE 2518 0.0251
469 CARDIAC FAILURE 2015 0.0251
470 ANURIA 215 0.0250
471 DYSPHAGIA 2371 0.0250
472 LIPASE INCREASED 191 0.0249
473 FACIAL PAIN 222 0.0248
474 PULMONARY EMBOLISM 2351 0.0247
475 ANHEDONIA 649 0.0247
476 HALLUCINATION, VISUAL 520 0.0246
477 NERVE COMPRESSION 227 0.0246
478 HYPERSOMNIA 704 0.0245
479 ABDOMINAL PAIN UPPER 5050 0.0245
480 CONTUSION 2361 0.0245
481 INITIAL INSOMNIA 251 0.0244
482 POST PROCEDURAL COMPLICATION 468 0.0243
483 FEEDING DISORDER 494 0.0243
484 OBESITY 388 0.0243
485 PYELONEPHRITIS 211 0.0243
486 BACK PAIN 5657 0.0243
487 HEPATIC STEATOSIS 453 0.0243
488 VITAMIN D DECREASED 207 0.0242
489 HEART RATE INCREASED 2392 0.0241
490 DRUG ERUPTION 427 0.0241
491 MUSCLE RIGIDITY 288 0.0241
492 DISSEMINATED INTRAVASCULAR COAGULATION 339 0.0241
493 ELECTROCARDIOGRAM QT PROLONGED 866 0.0241
494 NAUSEA 19040 0.0240
495 PERIPHERAL SWELLING 3704 0.0240
496 MUSCLE STRAIN 208 0.0240
497 LIVER FUNCTION TEST ABNORMAL 698 0.0240
498 HAEMARTHROSIS 215 0.0240
499 DYSPHONIA 1403 0.0240
500 HIP FRACTURE 771 0.0239
501 EAR DISCOMFORT 246 0.0239
502 METABOLIC ACIDOSIS 765 0.0239
503 MOBILITY DECREASED 1718 0.0239
504 STOMATITIS 1448 0.0239
505 GINGIVAL PAIN 190 0.0238
506 OSTEOMYELITIS 432 0.0238
507 GASTRIC ULCER 451 0.0237
508 OROPHARYNGEAL DISCOMFORT 214 0.0237
509 JOINT INJURY 506 0.0237
510 HEART RATE IRREGULAR 535 0.0237
511 RASH MACULO-PAPULAR 526 0.0236
512 HERNIA 457 0.0236
513 HAEMODIALYSIS 198 0.0236
514 DYSARTHRIA 884 0.0235
515 MUSCULAR WEAKNESS 2664 0.0234
516 DYSPEPSIA 2306 0.0234
517 EATING DISORDER 497 0.0233
518 DENTAL CARIES 258 0.0233
519 EAR PAIN 453 0.0233
520 FEELING COLD 648 0.0233
521 BRAIN FOG 364 0.0232
522 PARKINSONISM 226 0.0232
523 DECREASED ACTIVITY 250 0.0232
524 HEART RATE DECREASED 809 0.0230
525 EMBOLISM 191 0.0230
526 FOOT FRACTURE 436 0.0230
527 BLOOD PRESSURE SYSTOLIC INCREASED 448 0.0229
528 BLOOD PRESSURE INCREASED 3508 0.0229
529 JAUNDICE 617 0.0229
530 PERITONITIS BACTERIAL 231 0.0229
531 MOTOR DYSFUNCTION 233 0.0228
532 PLASMA CELL MYELOMA 892 0.0228
533 EXTRA DOSE ADMINISTERED 926 0.0228
534 RESTLESS LEGS SYNDROME 414 0.0227
535 ATAXIA 269 0.0226
536 MYOPATHY 195 0.0226
537 ILLNESS 2324 0.0225
538 DRY MOUTH 1825 0.0225
539 INTERVERTEBRAL DISC PROTRUSION 490 0.0224
540 THROAT IRRITATION 1005 0.0224
541 WRIST FRACTURE 268 0.0223
542 PLATELET COUNT INCREASED 291 0.0223
543 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 378 0.0222
544 BODY TEMPERATURE DECREASED 219 0.0222
545 DISORIENTATION 881 0.0222
546 SEIZURE 2563 0.0222
547 GLAUCOMA 427 0.0221
548 PRESCRIBED UNDERDOSE 442 0.0221
549 SCIATICA 353 0.0221
550 HYPOTHERMIA 224 0.0221
551 RHINORRHOEA 1430 0.0221
552 IMPAIRED QUALITY OF LIFE 318 0.0221
553 LUNG DISORDER 1082 0.0221
554 NEPHROLITHIASIS 1012 0.0220
555 SKIN ULCER 570 0.0220
556 PRODUCT PRESCRIBING ERROR 525 0.0220
557 INFECTION 3189 0.0220
558 LEUKOPENIA 1102 0.0220
559 NECK PAIN 1230 0.0220
560 PROCEDURAL PAIN 610 0.0220
561 INFLUENZA 2450 0.0219
562 MYOCARDITIS 251 0.0219
563 POLLAKIURIA 913 0.0219
564 ACUTE RESPIRATORY DISTRESS SYNDROME 387 0.0219
565 FUNGAL INFECTION 729 0.0218
566 NEUTROPENIA 2970 0.0218
567 COVID-19 3830 0.0218
568 PRESCRIBED OVERDOSE 422 0.0218
569 THYROID DISORDER 336 0.0218
570 MUSCULOSKELETAL DISCOMFORT 375 0.0218
571 BLOOD URINE PRESENT 413 0.0217
572 HYPOTONIA 216 0.0216
573 HYPERTENSION 4568 0.0215
574 HYPOGLYCAEMIA 1044 0.0215
575 LOWER RESPIRATORY TRACT INFECTION 978 0.0215
576 GASTROINTESTINAL DISORDER 1924 0.0215
577 ERUCTATION 415 0.0214
578 ACUTE MYOCARDIAL INFARCTION 632 0.0214
579 HEMIPARESIS 363 0.0214
580 HAEMORRHAGE INTRACRANIAL 320 0.0214
581 OFF LABEL USE 18736 0.0214
582 APHASIA 646 0.0214
583 COLD SWEAT 377 0.0214
584 ABDOMINAL DISCOMFORT 3584 0.0213
585 COMPLICATION ASSOCIATED WITH DEVICE 310 0.0213
586 FATIGUE 16577 0.0213
587 RENAL DISORDER 989 0.0212
588 RENAL IMPAIRMENT 1772 0.0211
589 PANCREATITIS ACUTE 474 0.0211
590 CARDIO-RESPIRATORY ARREST 881 0.0210
591 RESPIRATORY DISORDER 630 0.0210
592 DELUSION 327 0.0210
593 OSTEOARTHRITIS 892 0.0210
594 MUSCLE SPASMS 3856 0.0210
595 PULMONARY THROMBOSIS 229 0.0210
596 BLOOD PRESSURE FLUCTUATION 502 0.0209
597 THROMBOSIS 1679 0.0208
598 GALLBLADDER DISORDER 372 0.0208
599 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 999 0.0208
600 OROPHARYNGEAL PAIN 1923 0.0208
601 ABDOMINAL PAIN LOWER 525 0.0207
602 TREMOR 3445 0.0207
603 OSTEOPOROSIS 853 0.0207
604 FLUSHING 2104 0.0207
605 PRODUCT ADMINISTRATION ERROR 416 0.0206
606 ABNORMAL BEHAVIOUR 815 0.0205
607 CHOKING 401 0.0205
608 PERIPHERAL COLDNESS 282 0.0205
609 BLOOD LACTATE DEHYDROGENASE INCREASED 325 0.0205
610 HYPERTHYROIDISM 296 0.0204
611 MUSCLE SPASTICITY 251 0.0204
612 SWOLLEN TONGUE 638 0.0204
613 SOMNOLENCE 4105 0.0204
614 POST PROCEDURAL HAEMORRHAGE 237 0.0203
615 LACERATION 191 0.0203
616 COMA 967 0.0203
617 BACK DISORDER 330 0.0203
618 LACTIC ACIDOSIS 657 0.0203
619 DRY THROAT 206 0.0202
620 SPINAL FRACTURE 406 0.0202
621 SHOCK 466 0.0202
622 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1437 0.0202
623 ARRHYTHMIA 956 0.0202
624 OBSTRUCTIVE AIRWAYS DISORDER 224 0.0201
625 MUSCLE TWITCHING 464 0.0201
626 SALIVARY HYPERSECRETION 201 0.0201
627 POOR QUALITY SLEEP 431 0.0200
628 UNEVALUABLE EVENT 1514 0.0200
629 HEPATIC ENZYME INCREASED 1362 0.0200
630 DIZZINESS 9957 0.0199
631 BURSITIS 242 0.0199
632 AGITATION 1461 0.0199
633 ACUTE MYELOID LEUKAEMIA 310 0.0199
634 BLOOD COUNT ABNORMAL 301 0.0198
635 BRONCHOSPASM 283 0.0198
636 UPPER LIMB FRACTURE 395 0.0198
637 DRUG LEVEL INCREASED 328 0.0198
638 HYPOKINESIA 286 0.0197
639 SLEEP DISORDER 1389 0.0197
640 TOOTH FRACTURE 216 0.0196
641 ANKLE FRACTURE 303 0.0196
642 HOSPITALISATION 3000 0.0195
643 HYPERHIDROSIS 2515 0.0195
644 SWELLING 1826 0.0195
645 LABORATORY TEST ABNORMAL 575 0.0195
646 PALPITATIONS 2281 0.0195
647 IMMUNODEFICIENCY 290 0.0194
648 ABSCESS 310 0.0194
649 DISEASE PROGRESSION 2290 0.0193
650 EPILEPSY 591 0.0193
651 INTESTINAL PERFORATION 217 0.0193
652 DIPLOPIA 502 0.0193
653 RESTLESSNESS 706 0.0193
654 PSYCHOTIC DISORDER 569 0.0192
655 ANGINA PECTORIS 552 0.0192
656 LOSS OF CONSCIOUSNESS 2465 0.0192
657 RASH ERYTHEMATOUS 918 0.0192
658 SPEECH DISORDER 1006 0.0192
659 PHARYNGITIS 237 0.0191
660 DYSSTASIA 557 0.0191
661 MUSCULOSKELETAL PAIN 999 0.0190
662 DRUG INTERACTION 3021 0.0190
663 STEVENS-JOHNSON SYNDROME 423 0.0190
664 DYSKINESIA 773 0.0190
665 DIALYSIS 269 0.0189
666 LIVER FUNCTION TEST INCREASED 407 0.0189
667 HEADACHE 11874 0.0189
668 TINNITUS 868 0.0189
669 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3393 0.0188
670 NERVE INJURY 209 0.0188
671 ISCHAEMIC STROKE 333 0.0186
672 THERAPY NON-RESPONDER 838 0.0186
673 MYOCLONUS 222 0.0186
674 MASS 260 0.0186
675 IRRITABLE BOWEL SYNDROME 398 0.0185
676 CHROMATURIA 419 0.0185
677 CHOLESTASIS 356 0.0185
678 NASOPHARYNGITIS 3407 0.0185
679 ANOREXIA 238 0.0184
680 PAIN IN EXTREMITY 5436 0.0184
681 METASTASES TO LIVER 324 0.0184
682 NIGHT SWEATS 593 0.0184
683 MUSCLE ATROPHY 233 0.0184
684 MIGRAINE 1755 0.0184
685 ORAL DISCOMFORT 255 0.0183
686 LIP SWELLING 611 0.0183
687 SWELLING FACE 1194 0.0183
688 ANXIETY 5218 0.0183
689 INTENTIONAL DOSE OMISSION 522 0.0183
690 METASTASES TO CENTRAL NERVOUS SYSTEM 236 0.0183
691 INJURY 1285 0.0183
692 HEPATOTOXICITY 407 0.0183
693 MYELODYSPLASTIC SYNDROME 264 0.0182
694 ANAPHYLACTIC SHOCK 470 0.0182
695 DRUG EFFECT LESS THAN EXPECTED 270 0.0182
696 THERAPY INTERRUPTED 1302 0.0182
697 SKIN REACTION 256 0.0182
698 BONE PAIN 1064 0.0181
699 RHABDOMYOLYSIS 756 0.0181
700 BLISTER 1018 0.0181
701 INCORRECT DOSE ADMINISTERED 4134 0.0181
702 WEIGHT INCREASED 4052 0.0181
703 DEVICE FAILURE 275 0.0180
704 TREATMENT NONCOMPLIANCE 987 0.0180
705 ROTATOR CUFF SYNDROME 231 0.0180
706 ALTERED STATE OF CONSCIOUSNESS 389 0.0179
707 NEUROTOXICITY 314 0.0179
708 HERPES ZOSTER 1029 0.0179
709 RASH PRURITIC 970 0.0179
710 PAIN 10975 0.0178
711 LYMPHADENOPATHY 631 0.0178
712 BEDRIDDEN 234 0.0178
713 CEREBRAL HAEMORRHAGE 636 0.0177
714 HAIR COLOUR CHANGES 221 0.0177
715 TOOTHACHE 321 0.0177
716 INTENTIONAL PRODUCT USE ISSUE 1553 0.0177
717 CONJUNCTIVITIS 328 0.0177
718 GAIT DISTURBANCE 3379 0.0176
719 LIMB DISCOMFORT 546 0.0176
720 AGEUSIA 440 0.0176
721 DYSGEUSIA 1310 0.0176
722 DISCOMFORT 1072 0.0176
723 MALAISE 7705 0.0176
724 PROSTATIC SPECIFIC ANTIGEN INCREASED 242 0.0175
725 ANAPHYLACTIC REACTION 970 0.0175
726 HYPOAESTHESIA ORAL 263 0.0174
727 STATUS EPILEPTICUS 197 0.0174
728 LIVER DISORDER 770 0.0173
729 ASTHMA 1962 0.0173
730 EOSINOPHILIA 304 0.0173
731 MUSCLE TIGHTNESS 281 0.0173
732 SKIN DISCOLOURATION 797 0.0173
733 CONDITION AGGRAVATED 5269 0.0173
734 GENERALISED TONIC-CLONIC SEIZURE 286 0.0173
735 TOOTH DISORDER 384 0.0173
736 RESPIRATORY ARREST 476 0.0173
737 HYPOAESTHESIA 2584 0.0172
738 METASTASES TO BONE 283 0.0172
739 MALIGNANT NEOPLASM PROGRESSION 1757 0.0171
740 CATARACT 1021 0.0171
741 PERITONITIS 354 0.0171
742 AGGRESSION 854 0.0170
743 RESPIRATORY DEPRESSION 209 0.0170
744 METASTASES TO LUNG 197 0.0170
745 ANGER 576 0.0170
746 DRUG TOXICITY 232 0.0170
747 GAIT INABILITY 569 0.0170
748 PARANOIA 293 0.0170
749 APHONIA 237 0.0170
750 WOUND 472 0.0169
751 NEUROLEPTIC MALIGNANT SYNDROME 200 0.0168
752 BLOOD CREATINE PHOSPHOKINASE INCREASED 485 0.0168
753 THIRST 301 0.0168
754 SKIN LESION 462 0.0168
755 VASCULITIS 196 0.0168
756 SCAR 288 0.0168
757 BONE DISORDER 306 0.0168
758 GASTRIC HAEMORRHAGE 193 0.0168
759 FEAR 449 0.0167
760 RASH PAPULAR 374 0.0167
761 LACRIMATION INCREASED 503 0.0166
762 PANCREATITIS 876 0.0166
763 HEAD DISCOMFORT 293 0.0165
764 PULMONARY FIBROSIS 317 0.0165
765 CORONARY ARTERY OCCLUSION 226 0.0165
766 AMNESIA 1072 0.0165
767 GASTRIC DISORDER 565 0.0164
768 DERMATITIS ALLERGIC 207 0.0164
769 INSOMNIA 4379 0.0164
770 CARDIAC DISORDER 1538 0.0164
771 DEPRESSION 3728 0.0164
772 DIABETES MELLITUS 1249 0.0164
773 MENTAL DISORDER 713 0.0164
774 BLOOD CHOLESTEROL INCREASED 762 0.0163
775 PHOTOPHOBIA 307 0.0163
776 HAEMORRHAGE 1706 0.0163
777 ACUTE HEPATIC FAILURE 222 0.0162
778 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 378 0.0162
779 TYPE 2 DIABETES MELLITUS 545 0.0162
780 IMPAIRED HEALING 531 0.0162
781 SPINAL OPERATION 199 0.0161
782 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1149 0.0161
783 THROAT TIGHTNESS 436 0.0161
784 PRODUCT DOSE OMISSION ISSUE 4738 0.0161
785 DRUG EFFECT DECREASED 861 0.0160
786 PROTEINURIA 303 0.0159
787 FEELING ABNORMAL 3818 0.0159
788 DIABETES MELLITUS INADEQUATE CONTROL 282 0.0159
789 LOWER LIMB FRACTURE 306 0.0159
790 TOOTH EXTRACTION 198 0.0159
791 ARTHRITIS 1251 0.0159
792 DRUG INTOLERANCE 1529 0.0158
793 NO THERAPEUTIC RESPONSE 193 0.0158
794 FEELING HOT 967 0.0158
795 MIDDLE INSOMNIA 294 0.0157
796 LYMPHOPENIA 222 0.0157
797 FACE OEDEMA 264 0.0156
798 BURNING SENSATION 1096 0.0156
799 EYE PAIN 880 0.0156
800 PRURITUS 5956 0.0155
801 MEMORY IMPAIRMENT 2119 0.0154
802 CONVULSION 882 0.0154
803 BASAL CELL CARCINOMA 240 0.0154
804 SNEEZING 344 0.0153
805 RASH 6651 0.0152
806 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 836 0.0152
807 SKIN DISORDER 508 0.0152
808 INCREASED APPETITE 291 0.0152
809 VERTIGO 922 0.0151
810 NODULE 196 0.0150
811 BLOOD TRIGLYCERIDES INCREASED 265 0.0150
812 RASH MACULAR 524 0.0150
813 CEREBRAL INFARCTION 366 0.0150
814 HOT FLUSH 1128 0.0150
815 ERYTHEMA 3075 0.0149
816 THERAPY PARTIAL RESPONDER 233 0.0149
817 THERAPEUTIC RESPONSE UNEXPECTED 670 0.0149
818 COORDINATION ABNORMAL 208 0.0149
819 THINKING ABNORMAL 276 0.0148
820 PARALYSIS 211 0.0147
821 PRODUCT DOSE OMISSION IN ERROR 417 0.0147
822 INTERSTITIAL LUNG DISEASE 712 0.0147
823 QUALITY OF LIFE DECREASED 197 0.0147
824 DEPRESSED MOOD 775 0.0146
825 HAIR TEXTURE ABNORMAL 196 0.0146
826 IMMUNE SYSTEM DISORDER 193 0.0146
827 MENTAL IMPAIRMENT 352 0.0145
828 PHARYNGEAL OEDEMA 223 0.0145
829 ABASIA 355 0.0144
830 PARAESTHESIA 2256 0.0143
831 BLOOD GLUCOSE DECREASED 686 0.0143
832 SENSORY DISTURBANCE 229 0.0143
833 CONTRAINDICATED PRODUCT ADMINISTERED 432 0.0143
834 ARTHRALGIA 5927 0.0142
835 NERVOUS SYSTEM DISORDER 444 0.0142
836 JOINT SWELLING 1709 0.0141
837 FEELING JITTERY 269 0.0141
838 ROAD TRAFFIC ACCIDENT 590 0.0141
839 PRODUCT PHYSICAL ISSUE 284 0.0141
840 VISION BLURRED 1929 0.0140
841 ACTIVITIES OF DAILY LIVING IMPAIRED 276 0.0139
842 MYALGIA 2364 0.0139
843 LOCAL SWELLING 241 0.0138
844 HALLUCINATION, AUDITORY 219 0.0138
845 COLON CANCER 205 0.0137
846 DISTURBANCE IN ATTENTION 741 0.0137
847 CRYING 497 0.0137
848 NERVOUSNESS 712 0.0136
849 CEREBROVASCULAR ACCIDENT 2292 0.0135
850 DRY EYE 675 0.0135
851 EYE SWELLING 501 0.0135
852 SYNOVITIS 242 0.0134
853 PHOTOSENSITIVITY REACTION 221 0.0134
854 HYPERSENSITIVITY 2475 0.0133
855 URTICARIA 2230 0.0133
856 SKIN HAEMORRHAGE 196 0.0132
857 MUSCULOSKELETAL STIFFNESS 1156 0.0132
858 HYPOACUSIS 568 0.0132
859 FEMUR FRACTURE 408 0.0132
860 DRUG ADMINISTRATION ERROR 403 0.0131
861 ACCIDENTAL OVERDOSE 480 0.0131
862 MOVEMENT DISORDER 421 0.0131
863 SKIN CANCER 281 0.0130
864 THERAPEUTIC PRODUCT EFFECT DECREASED 583 0.0130
865 ORAL HERPES 253 0.0129
866 NEOPLASM PROGRESSION 449 0.0129
867 DEAFNESS 337 0.0129
868 SURGERY 751 0.0128
869 DRUG INEFFECTIVE 16871 0.0128
870 GLOSSODYNIA 286 0.0128
871 IRRITABILITY 767 0.0127
872 EYE DISORDER 419 0.0127
873 INFLUENZA LIKE ILLNESS 1044 0.0127
874 EMOTIONAL DISORDER 391 0.0127
875 CARDIOVASCULAR DISORDER 321 0.0126
876 MEDICATION ERROR 699 0.0126
877 MYOCARDIAL INFARCTION 2190 0.0125
878 DEATH 10768 0.0125
879 BLOOD GLUCOSE INCREASED 2354 0.0125
880 PRURITUS GENERALISED 270 0.0125
881 OSTEONECROSIS OF JAW 306 0.0124
882 DEVICE DISLOCATION 537 0.0123
883 JOINT STIFFNESS 323 0.0123
884 HEPATITIS 315 0.0123
885 PRODUCT AVAILABILITY ISSUE 280 0.0123
886 PSYCHOMOTOR HYPERACTIVITY 202 0.0122
887 DERMATITIS 255 0.0122
888 NIGHTMARE 421 0.0122
889 PERICARDITIS 204 0.0121
890 ANGIOEDEMA 535 0.0121
891 PRODUCT PREPARATION ERROR 247 0.0120
892 PANIC ATTACK 438 0.0120
893 INTENTIONAL PRODUCT MISUSE 1049 0.0120
894 ARTHROPATHY 665 0.0120
895 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2422 0.0119
896 THERAPY CESSATION 610 0.0119
897 PRODUCT DISPENSING ERROR 258 0.0118
898 TOXICITY TO VARIOUS AGENTS 1997 0.0118
899 MOOD ALTERED 322 0.0118
900 CYTOMEGALOVIRUS INFECTION 196 0.0118
901 EYE PRURITUS 395 0.0117
902 MOOD SWINGS 374 0.0117
903 PRODUCT DOSE OMISSION 763 0.0117
904 PHARMACEUTICAL PRODUCT COMPLAINT 301 0.0116
905 ILL-DEFINED DISORDER 699 0.0115
906 KNEE ARTHROPLASTY 241 0.0114
907 OCULAR HYPERAEMIA 541 0.0114
908 FRACTURE 215 0.0113
909 ALOPECIA 2230 0.0113
910 BLOOD GLUCOSE ABNORMAL 209 0.0113
911 VISUAL IMPAIRMENT 1402 0.0113
912 PREMATURE BABY 340 0.0113
913 SEROTONIN SYNDROME 216 0.0112
914 COLITIS ULCERATIVE 502 0.0112
915 ADVERSE DRUG REACTION 1006 0.0112
916 SKIN FISSURES 217 0.0111
917 PELVIC PAIN 201 0.0111
918 WRONG TECHNIQUE IN DRUG USAGE PROCESS 400 0.0110
919 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 322 0.0110
920 LUNG NEOPLASM MALIGNANT 448 0.0109
921 INFLAMMATION 562 0.0109
922 RASH GENERALISED 281 0.0108
923 DIABETIC KETOACIDOSIS 260 0.0108
924 OVERDOSE 2317 0.0107
925 SKIN EXFOLIATION 888 0.0105
926 EMOTIONAL DISTRESS 1271 0.0105
927 BLINDNESS 427 0.0105
928 DYSTONIA 202 0.0104
929 ADVERSE EVENT 957 0.0104
930 TOOTH LOSS 213 0.0103
931 DRY SKIN 1369 0.0102
932 DEVICE ISSUE 904 0.0101
933 ABNORMAL DREAMS 272 0.0098
934 EYE IRRITATION 559 0.0097
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 245 0.0097
936 DRUG EFFECT INCOMPLETE 351 0.0097
937 DISABILITY 189 0.0095
938 ECZEMA 500 0.0095
939 PAIN OF SKIN 257 0.0095
940 NEOPLASM MALIGNANT 629 0.0094
941 DEVICE LEAKAGE 407 0.0094
942 IMPAIRED WORK ABILITY 189 0.0088
943 SYSTEMIC LUPUS ERYTHEMATOSUS 311 0.0088
944 DISEASE RECURRENCE 404 0.0085
945 VISUAL ACUITY REDUCED 282 0.0085
946 VAGINAL HAEMORRHAGE 368 0.0085
947 THERAPEUTIC RESPONSE DECREASED 508 0.0084
948 MATERNAL EXPOSURE DURING PREGNANCY 719 0.0081
949 MULTIPLE SCLEROSIS 385 0.0080
950 NEEDLE ISSUE 232 0.0080
951 OSTEONECROSIS 261 0.0079
952 DRUG DOSE OMISSION 1299 0.0079
953 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 202 0.0078
954 SUICIDAL IDEATION 717 0.0078
955 PRODUCT QUALITY ISSUE 1057 0.0078
956 THERAPEUTIC RESPONSE SHORTENED 253 0.0076
957 MULTIPLE SCLEROSIS RELAPSE 520 0.0076
958 EXPOSURE DURING PREGNANCY 470 0.0076
959 COMPLETED SUICIDE 624 0.0075
960 BONE DENSITY DECREASED 223 0.0071
961 NO ADVERSE EVENT 1282 0.0071
962 WITHDRAWAL SYNDROME 293 0.0070
963 RHEUMATOID ARTHRITIS 791 0.0070
964 DEVICE MALFUNCTION 481 0.0068
965 TARDIVE DYSKINESIA 193 0.0068
966 TREATMENT FAILURE 566 0.0068
967 PANCREATIC CARCINOMA 197 0.0068
968 DEVICE USE ERROR 236 0.0068
969 INTENTIONAL OVERDOSE 386 0.0060
970 INJECTION SITE MASS 217 0.0059
971 INJECTION SITE PRURITUS 381 0.0057
972 FOETAL EXPOSURE DURING PREGNANCY 449 0.0055
973 DEVICE BREAKAGE 220 0.0054
974 PSORIATIC ARTHROPATHY 219 0.0054
975 INJECTION SITE ERYTHEMA 663 0.0053
976 SUICIDE ATTEMPT 324 0.0053
977 INJECTION SITE BRUISING 419 0.0052
978 SKIN IRRITATION 233 0.0051
979 PRODUCT SUBSTITUTION ISSUE 290 0.0050
980 INJECTION SITE SWELLING 380 0.0050
981 DRUG ABUSE 406 0.0049
982 ACNE 368 0.0048
983 DRUG WITHDRAWAL SYNDROME 423 0.0048
984 INJECTION SITE PAIN 1437 0.0047
985 INJECTION SITE HAEMORRHAGE 372 0.0047
986 INJECTION SITE REACTION 294 0.0043
987 BREAST CANCER 393 0.0042
988 PSORIASIS 548 0.0042
989 DRUG DEPENDENCE 586 0.0036
990 SKIN BURNING SENSATION 258 0.0036
991 DEVICE DIFFICULT TO USE 220 0.0033
992 PROSTATE CANCER 233 0.0029
993 ACCIDENTAL EXPOSURE TO PRODUCT 297 0.0029
994 PRODUCT STORAGE ERROR 245 0.0028